[关于肠道微生物和细胞因子在炎症性肠病中的相互作用的研究进展]
Xinyu Lu1, Shuli Zhang1, Xiaofeng Li1
1School of Medical Technology, Xi'an Medical University, Xi'an 710021, China.
概括
肠道微生物群的失调和免疫系统的相互作用导致慢性炎症,如炎症性肠病 (IBD). 了解肠道微生物群和细胞因子相互作用对于IBD病原体的洞察至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 慢性炎症,包括炎症性肠病 (IBD),源于肠道微生物群与宿主免疫系统相互作用的破坏.
- 免疫系统的稳定性受到IBD患者肠道微生物群的显著影响.
- 保持健康的微生物群和强大的上皮屏障功能取决于促炎和抗炎细胞因子的平衡.
研究的目的:
- 阐明肠道微生物群和宿主免疫反应在IBD病变发生过程中的复杂关系.
- 突出特定细胞因子在调节肠道微生物群和IBD相关的免疫平衡中的作用.
- 为了解IBD慢性炎症背后的机制提供见解.
主要方法:
- 审查关于肠道微生物群,免疫系统和IBD中的细胞因子概况的现有文献.
- 对调查微生物群失生症对免疫细胞功能和细胞因子产生影响的研究进行分析.
- 特定细胞因子水平 (IL-10,IL-17,IL-18,TNF-α) 与IBD状态和微生物群组成的相关性.
主要成果:
- 肠道微生物群的失调是IBD发展和进展的关键因素.
- 特定的促炎和抗炎细胞因子在IBD病变发生过程中起着关键作用.
- 微生物群和细胞因子之间的相互作用直接影响免疫系统的恒常性和上皮屏障完整性.
结论:
- 了解肠道微生物群和细胞因子之间的复杂相互作用对于破译IBD病变发生是必不可少的.
- 准微生物群与宿主免疫系统相互作用和细胞因子平衡可能为IBD提供治疗策略.
- 对这些相互作用的进一步研究可以揭示治疗慢性肠道炎症的新途径.
更多相关视频
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
263
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
263
01:29Inflammatory Bowel Disease IV: Pharmacological Management
123
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
123
01:30Inflammatory Bowel Disease II: Crohn's Disease
205
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
205
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
159
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
159
01:17Chronic Bowel Disorders: Introduction
420
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
420
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
329
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
329